Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery

References

• Lu Y, Li Y, Wu W. Injected nanocrystals for targeted drug delivery. Acta Pharm Sin B. 2016;6:106–113.
   PubMed Web of Science ®Google Scholar
• Kumari P, Ghosh B, Biswas S. Nanocarriers for cancer-targeted drug delivery. J Drug Target. 2016;24:179–191.
   PubMed Web of Science ®Google Scholar
• Alexis F, Pridgen EM, Langer R, et al. Nanoparticle technologies for cancer therapy. In Korting MS, editors. Handbook of experimental pharmacology. Berlin: Springer; 2009. p. 55–86.
   Google Scholar
• Parveen S, Misra R, Sahoo SK. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine. 2012;8:147–166.
   PubMed Web of Science ®Google Scholar
• Sun T, Zhang YS, Pang B, et al. Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed Engl. 2014;53:12320–12364.
   PubMed Web of Science ®Google Scholar
• Prokop A, Davidson JM. Nanovehicular intracellular delivery systems. J Pharm Sci. 2008;97:3518–3590.
   PubMed Web of Science ®Google Scholar
• Singh R, Lillard JW. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 2009;86:215–223.
   PubMed Web of Science ®Google Scholar
• Peppas LB, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 2012;64:206–212.
   Web of Science ®Google Scholar
• Markman JL, Rekechenetskiy A, Holler E, et al. Nanomedicine therapeutic approaches to overcome cancer drug resistance. Adv Drug Deliv Rev. 2013;65:1866–1879.
   PubMed Web of Science ®Google Scholar
• Rampino A, Borgogna M, Blasi P, et al. Chitosan nanoparticles: preparation, size evolution and stability. Int J Pharm. 2013;455:219–228.
   PubMed Web of Science ®Google Scholar
• Wang JJ, Zeng ZW, Xiao RZ, et al. Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomed. 2011;6:765–774.
   PubMed Web of Science ®Google Scholar
• Deng L, Qi H, Yao C, et al. Investigation on the properties of methoxy poly(ethylene glycol)/chitosan graft co-polymers. J Biomater Sci Polym Ed. 2007;18:1575–1589.
   PubMed Web of Science ®Google Scholar
• Ma G, Yang D, Zhou Y, et al. Preparation and characterization of water-soluble N-alkylated chitosan. Carbohydr Polym. 2008;74:121–126.
   Web of Science ®Google Scholar
• Murdan S. Solutions, Dosage form design and manufacture. In Aulton ME, Taylor KMG, editors. Aulton’s pharmaceutics: the design and manufacture of medicines. 4th ed. Netherlands: Churchill Livingstone; 2013. p. 395–405.
   Google Scholar
• Chen XG, Park HJ. Chemical characteristics of O-carboxymethylchitosans related to the preparation conditions. Carbohydr Polym. 2003;53:355–359.
   Web of Science ®Google Scholar
• Dong AJ, Feng MH, Qi HY, et al. Synthesis and properties of O-carboxymethyl chitosan/methoxy poly(ethylene glycol) graft copolymers. J Mater Sci Mater Med. 2008;19:869–876.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Li J, Lu F, et al. A study on the hemocompatibility of dendronized chitosan derivatives in red blood cells. Drug Des Devel Ther. 2015;9:2635–2645.
   PubMed Web of Science ®Google Scholar
• Casettari L, Vllasaliu D, Mantovani G, et al. Effect of PEGylation on the toxicity and permeability enhancement of chitosan. Biomacromolecules. 2010;11:2854–2865.
   PubMed Web of Science ®Google Scholar
• Chang SJ, Niu CC, Huang CF, et al. Evaluation of chitosan-g-PEG copolymer for cell anti-adhesion application. J Med Biol Eng. 2007;27:41–46.
   Google Scholar
• Zheng JN, Xie HG, Yu WT, et al. Chitosan-g-MPEG-modified alginate/chitosan hydrogel microcapsules: a quantitative study of the effect of polymer architecture on the resistance to protein adsorption. Langmuir. 2010;26:17156–17164.
   PubMed Web of Science ®Google Scholar
• Peng H, Xiong H, Li J, et al. Methoxy poly (ethylene glycol)-grafted-chitosan based microcapsules: synthesis, characterization and properties as a potential hydrophilic wall material for stabilization and controlled release of algal oil. J Food Eng. 2010;101:113–119.
   Web of Science ®Google Scholar
• Kim J, Wilson DR, Zamboni CG, et al. Targeted polymeric nanoparticles for cancer gene therapy. J Drug Target. 2015;23:627–641.
   PubMed Web of Science ®Google Scholar
• Kocbek P, Obermajer N, Cegnar M, et al. Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. J Control Release. 2007;120:18–26.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Song X, Darby M, et al. Preparation and characterization of folate-poly(ethylene glycol)-grafted-trimethylchitosan for intracellular transport of protein through folate receptor-mediated endocytosis. J Biotechnol. 2010;145:47–53.
   PubMed Web of Science ®Google Scholar
• Zhang T, Yu YY, Li D, et al. Synthesis and properties of a novel methoxy poly(ethylene glycol)-modified galactosylated chitosan derivative. J Mater Sci Mater Med. 2009;20:673–680.
   PubMed Web of Science ®Google Scholar
• Gorochovceva N, Makuska R. Synthesis and study of water-soluble chitosan-O-poly(ethylene glycol) graft copolymers. Eur Polym J. 2004;40:685–691.
   Web of Science ®Google Scholar
• Lin WJ, Chen TD, Liu CW, et al. Synthesis of lactobionic acid-grafted-pegylated-chitosan with enhanced HepG2 cells transfection. Carbohydr Polym. 2011;83:898–904.
   Web of Science ®Google Scholar
• Malhotra M, Duchesneau CT, Saha S, et al. Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA. Int J Nanomed. 2013;8:2041–2052.
   PubMed Web of Science ®Google Scholar
• Papadimitriou SA, Achilias DS, Bikiaris DN. Chitosan-g-PEG nanoparticles ionically crosslinked with poly(glutamic acid) and tripolyphosphate as protein delivery systems. Int J Pharm. 2012;430:318–327.
   PubMed Web of Science ®Google Scholar
• Shen JM, Tang WJ, Zhang XL, et al. A novel carboxymethyl chitosan-based folate/Fe3O4/CdTe nanoparticle for targeted drug delivery and cell imaging. Carbohydr Polym. 2012;88:239–249.
   Web of Science ®Google Scholar
• Sahu SK, Santra S, Ghosh SK, et al. In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery. J Mater Sci: Mater Med. 2010;21:1587–1597.
   PubMed Web of Science ®Google Scholar
• Chourasiya V, Bohrey S, Pandey A. Hydrochlorothiazide containing PLGA nanoparticles: design, characterization, in-vitro drug release and release kinetic study. Polym Sci Ser B. 2015;57:645–653.
   Web of Science ®Google Scholar
• Liu X, Jin Q, Ji Y, et al. Minimizing nonspecific phagocytic uptake of biocompatible gold nanoparticles with mixed charged zwitter ionic surface modification. J Mater Chem. 2012;22:1916–1927.
   Web of Science ®Google Scholar
• Hou Z, Zhan C, Jiang Q, et al. Both FA- and mPEG-conjugated chitosan nanoparticles for targeted cellular uptake and enhanced tumor tissue distribution. Nanoscale Res Lett. 2011;6:563.
   PubMed Web of Science ®Google Scholar
• Ayano E, Karaki M, Ishihara T, et al. Poly (N-isopropylacrylamide)-PLA and PLA blend nanoparticles for temperature-controllable drug release and intracellular uptake. Colloids Surf B Biointerfaces. 2012;99:67–73.
   PubMed Web of Science ®Google Scholar
• Matute AIR, Cobas AC, Bermejo ABG, et al. Synthesis, characterization and functional properties of galactosylated derivatives of chitosan through amide formation. Food Hydrocoll. 2013;33:245–255.
   Web of Science ®Google Scholar
• Mohanasrinivasan V, Mishra M, Paliwal JS, et al. Studies on heavy metal removal efficiency and antibacterial activity of chitosan prepared from shrimp shell waste. 3 Biotech. 2014;4:167–175.
   PubMedGoogle Scholar
• Kaasalainen M, Makila E, Riikonen J, et al. Effect of isotonic solutions and peptide adsorption on zeta potential of porous silicon nanoparticle drug delivery formulations. Int J Pharm. 2012;431:230–236.
   PubMed Web of Science ®Google Scholar
• Fresta M, Puglisi G, Giammona G, et al. Pefloxacine mesilate- and ofloxacin-loaded polyethylcyanoacrylate nanoparticles: characterization of the colloidal drug carrier formulation. J Pharm Sci. 1995;84:895–902.
   PubMed Web of Science ®Google Scholar
• Radwan MA. In vitro evaluation of polyisobutylcyanoacrylate nanoparticles as a controlled drug carrier for theophylline. Drug Dev Ind Pharm. 1995;21:2371–2375.
   Web of Science ®Google Scholar
• Chandel AKS, Kumar CU, Jewrajka SK. Effect of polyethylene glycol on properties and drug encapsulation release performance of biodegradable/cytocompatible agarose − polyethylene glycol − polycaprolactone amphiphilic co-network gels. ACS Appl Mater Interf. 2016;8:3182–3192.
   PubMed Web of Science ®Google Scholar
• Alexis F, Pridgen E, Molnar LK, et al. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 2008;5:505–515.
   PubMed Web of Science ®Google Scholar
• Yu B, Tai HC, Weiming X, et al. Receptor-targeted nanocarriers for therapeutic delivery to cancer. Mol Membr Biol. 2010;27:286–298.
   PubMed Web of Science ®Google Scholar
• Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 8:579–591.
   PubMed Web of Science ®Google Scholar
• Tarlovsky VF. Role of antioxidants in cancer therapy. Nutrition. 2013;29:15–21.
   PubMed Web of Science ®Google Scholar